New Study Finds One in Five Drivers Use a Prescription Drug That Can Impair Driving Despite Warnings – APhA submits compounding comments to FDA. – (866) 348-2889
A new study, which analyzes data from the National Roadside Survey of Alcohol and Drug Use, 2013-2014, found that one in five drivers have taken prescription drugs that could impair driving despite having been warned about the risks. The authors of the study, “Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers,” indicate that of the 7,405 random drivers who completed the prescription drug portion of the survey, almost 20% reported recent use (within the past two days) of a potentially impairing prescription drug.
Lead study author Robin Pollini told Reuters Health that she hopes her research will remind physicians and pharmacists to thoroughly discuss the potential risks of medications with their patients. Compared to people who were prescribed antidepressants (62.6%) and stimulants (57.7%), those who were prescribed sedatives (85.8%) and narcotics (85.1%) were most likely to report receiving warnings about the potential of these drugs to affect driving from their health care provider, pharmacy staff, or medication label.